SCHEMBL21386079

SCHEMBL21386079

CCNCCc1ncccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ HTR2A P28223 1/20 0.37
▸ HRH3 Q9Y5N1 2/20 0.35
▸ HTT P42858 1/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ TAAR1 Q96RJ0 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ HRH4 Q9H3N8 1/20 0.34
▸ SLC6A2 P23975 2/20 0.34
▸ SLC6A4 P31645 2/20 0.34
▸ NSD2 O96028 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ RET P07949 1/20 0.34
▸ ADRB2 P07550 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18236746 0.84 SIGMAR1 (0.37) ALDH1A1CYP2C19CYP1A2HRH3LMNA
SCHEMBL736789 0.78 — —
SCHEMBL17843167 0.77 HTR2A (0.38) CYP2C19CYP1A2HTR2AHRH3KMT2A
SCHEMBL20079218 0.77 ALDH1A1 (0.35) ALDH1A1CYP2C19CYP1A2HRH3LMNA
SCHEMBL18233550 0.77 ALDH1A1 (0.64) ALDH1A1CYP2C19CYP1A2HRH3KMT2A
SCHEMBL12606599 0.76 HRH3 (0.57) ALDH1A1HRH3KMT2AMEN1LMNA
SCHEMBL13100181 0.76 POLB (0.35) ALDH1A1
SCHEMBL22924121 0.76 HRH3 (0.36) ALDH1A1CYP2C19CYP1A2HRH3LMNA
Ammonia Solution, Strong SCHEMBL19437631 0.75 KDM4E (0.37) ALDH1A1LMNAMAPT
SCHEMBL746674 0.75 CYP1A2 (0.67) ALDH1A1CYP2C19CYP1A2HRH3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3294732-B1 BENZIMIDAZOLE AND IMADAZOPYRIDINE CARBOXIMIDAMIDE COMPOUNDS HAVING ACTIVITY AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE GILEAD SCIENCES INC (US) 2019-09-25 — — EP disclosed
Send feedback